0
0

Department of Health and Human Services Awarded a Contract to AGISOL LLC for $3,508,732.19

Signed on

7/16/2025, 12:00 AM

AGISOL LLC Government Contract #75F40125F80116

AGISOL LLC was awarded a contract with the United States Government for $3,508,732.19. The contract was awarded by the agency office FDA OFFICE OF ACQ GRANT SVCS, which is a division with the Food and Drug Administration within the Department of Health and Human Services.

Summary of Award

The recipient of the federal contract is AGISOL LLC, a small business located in Marriottsville, Maryland. The contract, funded by the Department of Health and Human Services through the Food and Drug Administration, is worth $1,388,693.67. The contract is for support services related to electronic records management. Notable details include the funding by a U.S.-owned business for computer systems design services and the firm fixed price contract.

Contract Details

Contract ID75F40125F80116
Contract TypeC
Total Obligation$1,388,693.67
Exercised Options$1,388,693.67
Base Amount + Options$3,508,732.19
Date Signed2025-07-16
Contract DescriptionFIRM FIXED PRICE AWARD CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) - REGULATORY REVIEW SYSTEMS ANALYSIS AND SUNSET SUPPORT CONTRACTING OFFICER REP (COR) JONATHAN RAPPAPORT TEL: 301-525-8444 JONATHAN RAPPAPORT@FDA.HHS.GOV CONTRACTING SPEC
Start Date2025-07-16
End Date2026-01-20

Agency Details

Awarding AgencyDepartment of Health and Human Services
Awarding Sub AgencyFood and Drug Administration
Awarding OfficeFDA OFFICE OF ACQ GRANT SVCS
Funding AgencyDepartment of Health and Human Services
Funding Sub AgencyFood and Drug Administration
Funding OfficeFDA OFFICE OF ACQ GRANT SVCS

Recipient Details

RecipientAGISOL LLC
Recipient Location11035 STRATFIELD CT MARRIOTTSVILLE MARYLAND, UNITED STATES
Business Categories8(a) Program Participant, Category Business, Corporate Entity Not Tax Exempt, Economically Disadvantaged Women Owned Small Business, Limited Liability Corporation, Minority Owned Business, Self-Certified Small Disadvantaged Business, Small Business, Special Designations, Indian (Subcontinent) American Owned Business, U.S.-Owned Business, Woman Owned Business, Women Owned Small Business

Comments

Award Transactions

Transaction #P00001$0.00October 28, 2025

Food and Drug Administration, a sub agency of Department of Health and Human Services, issued a payment of $0.00 to AGISOL LLC. The payment included a Subsidy Cost of $0.00.

This payment could indicate a change to the existing contract.

Transaction #0$1,388,693.67July 16, 2025

Food and Drug Administration, a sub agency of Department of Health and Human Services, issued a payment of $1,388,693.67 to AGISOL LLC. The payment included a Subsidy Cost of $0.00.

Transaction #P00002$2,120,038.52January 21, 2026

Food and Drug Administration, a sub agency of Department of Health and Human Services, issued a payment of $2,120,038.52 to AGISOL LLC. The payment included a Subsidy Cost of $0.00.

Transaction #P00001$0.00October 28, 2025

Food and Drug Administration, a sub agency of Department of Health and Human Services, issued a payment of $0.00 to AGISOL LLC. The payment included a Subsidy Cost of $0.00.

This payment could indicate a change to the existing contract.

Transaction #0$1,388,693.67July 16, 2025

Food and Drug Administration, a sub agency of Department of Health and Human Services, issued a payment of $1,388,693.67 to AGISOL LLC. The payment included a Subsidy Cost of $0.00.

Latest Bills

A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Limited Applicability of Consumer Financial Protection Act's 'Time or Space' Exception With Respect to Digital Marketing Providers".
Bill SJRES 150April 1, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the National Credit Union Administration relating to "Withdrawal of Fee Reporting Requirements".
Bill SJRES 142April 1, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Financial Protection Circular 2023-02: Reopening Deposit Accounts That Consumers Previously Closed".
Bill SJRES 143April 1, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Statement of Policy Regarding Prohibition on Abusive Acts or Practices".
Bill SJRES 147April 1, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Fair Credit Reporting; Permissible Purposes for Furnishing, Using, and Obtaining Consumer Reports".
Bill SJRES 145April 1, 2026
ESCRA Act
Bill S 4144April 1, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to "Fair Credit Reporting Act; Preemption of State Laws".
Bill SJRES 144April 1, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Application of Regulation Z's Ability-To-Repay Rule to Certain Situations Involving Successors-In-Interest".
Bill SJRES 146April 1, 2026
Proprietary Education Oversight Task Force Act
Bill S 4056April 1, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Debt Collection Practices (Regulation F); Deceptive and Unfair Collection of Medical Debt".
Bill SJRES 141April 1, 2026